MYCN and neoplasm: Despite difficulties in directly targeting MYCN, the bromodomain-mediated inhibition of MYCN attenuated tumor growth and induced apoptosis, conferring a survival advantage in three in vivo models of neuroblastoma (Puissant et al., 2013).